Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.

Item

http://www.wikidata.org/entity/Q38144094

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.

@en

type

Item

label

Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.

@en

prefLabel

Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.

@en

P1476

Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.

@en

P2093

Roberta A Berard

http://www.w3.org/2001/XMLSchema#string

Ronald M Laxer

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis

Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.

Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome.

The German etanercept registry for treatment of juvenile idiopathic arthritis.

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

P304

1623-1630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2013.840580

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24070010

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis